Marketing-authorisation holder · Canada
Vpi Pharmaceuticals Inc
7 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| VPI-AMIKACIN500 mg / 2 ml · Solution | Amikacin | Canada | Not marketed | 2021 |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION36 g / vial + 4.5 g / vial · Powder For Solution | Piperacillin, Tazobactam | Canada | Authorised | |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION3 g / vial + 0.375 g / vial · Powder For Solution | Piperacillin, Tazobactam | Canada | Authorised | |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION4 g / vial + 0.5 g / vial · Powder For Solution | Piperacillin, Tazobactam | Canada | Authorised | |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION2 g / vial + 0.25 g / vial · Powder For Solution | Piperacillin, Tazobactam | Canada | Authorised | |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION12 g / vial + 1.5 g / vial · Powder For Solution | Piperacillin, Tazobactam | Canada | Authorised | |
| STASON-LETROZOLE2.5 mg · Tablet | Letrozole | Canada | Cancelled |